The DOI matches its Crossref record.
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain
Abstract
The existence of multiple muscarinic receptors in the brain was investigated by using neurotransmitter release as a functional parameter and by comparing the effects of agonists and antagonists on three systems of release regulation mediated by presynaptic muscarinic receptors. The receptors selected as models for our experiments were: 1) the muscarinic autoreceptors mediating inhibition of acetylcholine release in the cortex; 2) the muscarinic autoreceptors present in the nerve endings of the hippocampus; and 3) the muscarinic presynaptic receptors mediating potentiation of striatal dopamine release (heteroreceptors). The experiments were performed by using rat brain synaptosomes in superfusion. Acetylcholine, oxotremorine and carbachol inhibited the release of [3H]acetylcholine evoked by 15 mM KCI in cortex and hippocampus and potentiated the K+-evoked [3H]dopamine release in the striatum. The concentration-response curves were similar in the three systems, the rank of potency being: acetylcholine greater than oxotremorine greater than carbachol. The effects of acetylcholine were counteracted by several muscarinic antagonists with different rank of potencies and different potency ratios. In particular, the rank of potencies for the drugs tested was: atropine greater than secoverine greater than stercuronium greater than pirenzepine at the autoreceptors, both in cortex and hippocampus; but it was: atropine greater than pirenzepine = secoverine greater than stercuronium, at the heteroreceptors in the striatum. Pirenzepine was 100 times more potent on heteroreceptors than on autoreceptors. Our results suggest the possibility of a differential activation or blockade of central muscarinic receptors by selective drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“presynaptic M2/M4 mAChRs can act as inhibitory autoreceptors on cholinergic terminals (Douglas et al., 2002; Raiteri et al., 1984) and reduce glutamate release from corticocortical and corticostriatal synapses (Higley et al 2009, Gil et al 1997).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Raiteri et al., 1984
Citations
Cited by
Sorted by citations
Items 201–300 of 314
Acetylcholine Measurement of Cerebrospinal Fluid by In Vivo Microdialysis in Freely Moving Rats
Togashi, H., Matsumoto, M., Yoshioka, M., et al. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.67 · Cited by 16
Wu, Y., Harp, P. R., Yan, X.-R., & Pope, C. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00121-7 · Cited by 15
Competitive interaction of pirenzepine with rat brain muscarinic acetylcholine receptors
El‐Fakahany, E. E., Cioffi, C. L., Abdellatif, M., et al. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90577-7 · Cited by 16
Dopamina: síntesis, liberación y receptores en el Sistema Nervioso Central.
Departamento de Fisiología, B. Y. N., Bahena-Trujillo, R., Flores, G., et al. (2000) · REVISTA BIOMÉDICA · doi:10.32776/revbiomed.v11i1.218 · Cited by 15
“glutamato, acetilcolina y serotonina (43,46,47).”
Muscarine-binding sites localized to cortical dopamine terminals
Liskowsky, D. R., & Potter, L. T. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90169-7 · Cited by 15
Hagan, J. J., Tonnaer, J. A. D. M., Rijk, H., et al. (1987) · Brain Research · doi:10.1016/s0006-8993(87)80021-5 · Cited by 15
The neurobiological effects of colchicine: Modulation by nerve growth factor
Barone, S., Bonner, M. J., Tandon, P., McGinty, J. F., & Tilson, H. A. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90188-4 · Cited by 15
Takahashi, L. K., & Goh, C.-S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00684-1 · Cited by 14
Tsushima, H., Mori, M., & MATSUDA, T. (1986) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.40.319 · Cited by 15
Llorente‐Ovejero, A., Martínez‐Gardeazabal, J., Moreno‐Rodríguez, M., Lombardero, L., Román, E. G. D. S., Manuel, I., Giralt, M. T., & Rodríguez‐Puertas, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00169 · Cited by 13
Psychiatry and Neuroscience Update
Perez‐Lloret, S., Peralta, M. C., & Barrantes, F. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17103-6 · Cited by 16
Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists
Cook, D. F., & Wirtshafter, D. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00184-8 · Cited by 14
Decreased (3H) quinuclidinyl benzilate binding to lymphocytes in Gilles de la Tourette syndrome
Rabey, J. M., Lewis, A., Graff, E., et al. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90115-g · Cited by 14
Schoffelmeer, A. N. M., Nestby, P., Tjon, G. H. K., Wardeh, G., Vries, T. J. D., Vanderschuren, L. J. M. J., & Mulder, A. H. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00588-7 · Cited by 14
Friedman, E., Wang, H. Y., & Butkerait, P. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90065-y · Cited by 14
Wichmann, T., & Starke, K. (1990) · Brain Research · doi:10.1016/0006-8993(90)91380-y · Cited by 14
Regulation of putative muscarinic cholinergic receptor subtypes in rat brain
Norman, A. B., Battaglia, G., & Creese, I. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90071-9 · Cited by 14
Xie, N., Bickley, B. A., & Gross, A. D. (2024) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2024.105972 · Cited by 13
Monmaur, P. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00282-7 · Cited by 13
Age-Related Alterations In Pre-Synaptic and Receptor-Mediated Cholinergic Functions In Rat Brain
Buyukuysal, R. L., Ulus, İ. H., & Kiran, B. K. (1998) · Neurochemical Research · doi:10.1023/a:1022403308819 · Cited by 13
“It is known since three decades that ACh release from cholinergic nerve endings can be modulated by muscarinic receptors (30-33).”
BackgroundRamcharan, E. J., & Matthews, M. R. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00478-5 · Cited by 13
Alonso, R., & Soubrié, P. (1991) · Synapse · doi:10.1002/syn.890080105 · Cited by 13
“Additionally, from lesion and release experiments, it has been suggested that M2 receptors are preferentially located on cholinergic terminals and control acetylcholine release (Raiteri et al., 1984; Mash et al., 1985; Lapchak et al., 1989; Vickroy and Cadman, 1989; Richards, 1990).”
BackgroundEffect of BM-5, a presynaptic antagonist-postsynaptic agonist, on cortical acetylcholine release
Casamenti, F., Cosi, C., & Pepeu, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90116-0 · Cited by 13
Gonzalez, J., Lignani, G., Maroto, M., Baldelli, P., & Hernández-Guijo, J. M. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht032 · Cited by 12
Altered fronto-striatal functions in the Gdi1-null mouse model of X-linked Intellectual Disability
Morè, L., Künnecke, B., Yekhlef, L., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.12.043 · Cited by 12
Acetylcholine-dopamine balance in striatum: Is it still a target for antiparkinsonian therapy?
Calabresi, P., Stefani, A., Mercuri, N. B., et al. (1989) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9138-7_31 · Cited by 12
Suzuki, T., Fujimoto, K., 大畑, 尚., et al. (1989) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(89)90023-2 · Cited by 12
Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice
Worms, P., & Bizière, K. (1987) · Psychopharmacology · doi:10.1007/bf00207240 · Cited by 12
“1985), an effect which is blocked by pirenzepine (Raiteri et al. 1984; Schoffelmeer et al. 1986).”
BackgroundBonanno, G., Marchi, M., & Raiteri, M. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90083-8 · Cited by 12
Self-citationChapter 21 Pharmacological muscarinic receptor subtypes
Ladinsky, H., Schiavi, G. B., Monferini, E., et al. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)60903-6 · Cited by 12
Decreased dopamine uptake into platelet storage granules in Gilles de la Tourette disease
Rabey, J. M., Oberman, Z., Graff, E., et al. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00234-t · Cited by 11
Presynaptic effects of methoctramine on release of acetylcholine
Törőcsik, A., & Vizi, E. S. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90157-7 · Cited by 11
Marchi, M., Paudice, P., Bonanno, G., et al. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90018-x · Cited by 11
Self-citationHirohumi, K. O. D. A., Hashimoto, T., & Kuriyama, K. (1989) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.49.215 · Cited by 11
Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat
Hirohumi, K. O. D. A., Hashimoto, T., & Kuriyama, K. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90341-5 · Cited by 11
Earley, B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00004-r · Cited by 10
Regulation of Extracellular Dopamine: Release and Uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00019-2 · Cited by 10
Joseph, J. A., Kandasamy, S. B., Hunt, W. A., et al. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90166-9 · Cited by 10
Hashimoto, S., Tanaka, C., & Taniyama, K. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb11183.x · Cited by 10
Vogt, B., Townes‐Anderson, E., & Dl, B. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-04-00959.1987 · Cited by 9
Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity
Bhattacharya, S. K., & Sen, A. P. (1992) · Journal of Neural Transmission · doi:10.1007/bf01250965 · Cited by 9
Monmaur, P., Puma, C., & Sharif, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91385-4 · Cited by 9
Marchi, M., Paudice, P., Gemignani, A., et al. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490170208 · Cited by 9
Self-citationOstenrath, A. M., Faturos, N., Çobanoğlu, Y. I. Ç., Serneels, B., Jeong, I., Dayanc, E. D., Enz, A., Hinrichsen, F., Mutlu, A. K., Bardenhewer, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62115-z · Cited by 8
“Besides GABA, neuromodulators such as dopamine 41 , serotonin 42 – 45 and acetylcholine 46,47 were also shown to mediate inhibition through their speci fi c inhibitory receptors.”
Mann, T., Zilles, K., Klawitter, F., Cremer, M., Hawlitschka, A., Palomero‐Gallagher, N., Schmitt, O., & Wree, A. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00065 · Cited by 8
Corronc, H. L., & Hue, B. (1991) · Pesticide Science · doi:10.1002/ps.2780330209 · Cited by 8
Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat
Marchi, M., Volpe, G., Augliera, A., et al. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90251-l · Cited by 8
Self-citationThe selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression
Wirtshafter, D. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.022 · Cited by 8
Wirtshafter, D. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.025 · Cited by 8
Effects of muscarinic receptor agonists and antagonists on dopamine-mediated behavioural paradigms
Bhattacharya, S. K., & Sen, A. P. (1991) · Journal of Neural Transmission · doi:10.1007/bf01244975 · Cited by 8
Pittaluga, A., Versace, P., Marchi, M., et al. (1987) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1987.tb00569.x · Cited by 8
Self-citationLee, K.-W., Tian, Y., You, I., Kwon, S., Ha, R.-R., Lee, S., Kim, H.-C., & Jang, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.021 · Cited by 7
Harada, H., Hosonuma, K., Fujii, T., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01013-2 · Cited by 7
Correlative Motor Behavioral and Striatal Dopaminergic Alterations Induced by 56Fe Radiation
Joseph, J. A., Hunt, W. A., Rabin, B. M., et al. (1988) · Springer eBooks · doi:10.1007/978-1-4613-1567-4_41 · Cited by 7
Allaoua, H., Chaudieu, I., Alonso, R., et al. (1993) · Synapse · doi:10.1002/syn.890150105 · Cited by 7
Cholinergic Modulation of Gabaergic Efferent Striatal Neurons
Mavridis, M., Kayadjanian, N., & Besson, M. J. (1994) · Advances in behavioral biology · doi:10.1007/978-1-4613-0485-2_45 · Cited by 7
Iino, T., Katsura, M., & Kuriyama, K. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00545-v · Cited by 6
mTOR Involvement in the Mechanisms of Memory
Giovannini, M. G., & Lana, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00018-9 · Cited by 7
Subtype specificity of the muscarinic receptor-stimulated GTPase response in the rat cortex
Ghodsi-Hovsepian, S., Messer, W. S., & Hoss, W. P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90803-h · Cited by 6
Regulation of Extracellular Dopamine
Sulzer, D., Zhang, H., Benoit‐Marand, M., & Gonon, F. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00017-2 · Cited by 8
Subtypes of Muscarinic Cholinergic Receptors
Wolfe, B. B. (1989) · Humana Press eBooks · doi:10.1007/978-1-4612-4498-1_4 · Cited by 6
Gilbert, R. J., & Dodds, W. J. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01300200 · Cited by 6
Costa, L. G., Kaylor, G., & Murphy, S. D. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00569398 · Cited by 5
Versace, P., Bocchieri, P., Marchi, M., et al. (1987) · Neurochemistry International · doi:10.1016/0197-0186(87)90008-8 · Cited by 5
Self-citationGulya, K., Budai, D., & Kása, P. (1989) · Neurochemistry International · doi:10.1016/0197-0186(89)90094-6 · Cited by 5
Alonso, R., Kan, J. P., Worms, P., et al. (1990) · Neurochemistry International · doi:10.1016/0197-0186(90)90028-r · Cited by 5
Two Drug Binding Sites on Muscarinic Receptors
Birdsall, N. J. M., Hulme, E. C., Krömer, W., et al. (1986) · doi:10.1007/978-1-349-08639-9_9 · Cited by 5
Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex
Lin, Y., & Phillis, J. W. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90663-b · Cited by 4
Moret, C., Pastrie, I., & Briley, M. (1989) · Neurochemistry International · doi:10.1016/0197-0186(89)90141-1 · Cited by 4
Cubeddu, L. X., Hoffmann, I., Talmaciu, R. K., et al. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90624-3 · Cited by 4
Meyer, E. M., Otero, D. H., Morgan, E., et al. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04117.x · Cited by 4
“In the rat cerebral cortex, these receptors appear to be predominantly the M2 type, based on their pirenzepine insensitivity and on the efficacy of oxotremorine (Raiteri et al., 1984; Meyer and Otero, 1985).”
BackgroundBiochemical and behavioral characterization of a novel cholinergic agonist, SR 95639
Boast, C. A., Leventer, S. M., Sabb, A. L., et al. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90181-z · Cited by 4
Neurochemical and Psychopharmacological Assessment of the M1-Selective Agonist AF102B (FKS-508)
Mizobe, F., Nakahara, N., Ogane, N., et al. (1990) · Advances in behavioral biology · doi:10.1007/978-1-4684-5847-3_71 · Cited by 4
Muscarinic Acetylcholine Receptors
Wess, J. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn005 · Cited by 4
Lloyd, J. T., Collins, A., Phillips, J. R., et al. (2025) · Vision Research · doi:10.1016/j.visres.2025.108656 · Cited by 3
Muscarinic and Nicotinic Receptors in Alzheimer’s Disease: Rationale for Cholinergic Drug Treatment
Lapchak, P. A., Araujo, D. M., & Quirion, R. (1989) · Advances in behavioral biology · doi:10.1007/978-1-4684-5727-8_6 · Cited by 3
Fabiani, M. E., Kabo, P., & Story, D. (1992) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1992.tb00516.x · Cited by 3
“With respect to our findings with rat atria, it has been established that acetylcholine released from cholinergic nerves in the hearts of a number of species may activate prejunctional muscarinic cholinoceptors and thereby inhibit transmitter release (Bourdois & Mitchell 1974; Szerb & Somogyi 1977; Marchi et al. 1981;…”
ResultHartvig, P., Nordberg, A. K., Torstenson, R., et al. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000057697 · Cited by 3
Digala, L. P., Murala, S., & Bollu, P. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-07897-2_11 · Cited by 3
Behavioral correlates of presynaptic events in the cholinergic neurotransmitter system
Russell, R. W. (1988) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9154-7_3 · Cited by 3
Yamamoto, T., Ohno, M., Sugimachi, K., et al. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90004-d · Cited by 3
Green, A. C., & Dowdall, M. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09746.x · Cited by 3
Loss of muscarinic regulation of striatal dopamine function in senescence
Joseph, J. A., & Roth, G. S. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90244-l · Cited by 3
Inhibition mediated by group III mGluRs regulates habenula activity and defensive behaviorsPreprint
Ostenrath, A. M., Faturos, N., Çobanoğlu, Y. I. Ç., Serneels, B., Jeong, I., Enz, A., Hinrichsen, F., Mutlu, A. K., Bardenhewer, R., Jetti, S. K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.11.612421 · Cited by 3
“Besides GABA, neuromodulators such as dopamine ( 41 ), serotonin ( 42-45 ) and acetylcholine ( 46, 47 ) were also shown to mediate inhibition through their specific inhibitory receptors.”
BackgroundRelease in vitro as a model to study neurotransmitter receptors
Raiteri, M. (1987) · Pharmacological Research Communications · doi:10.1016/0031-6989(87)90042-7 · Cited by 2
Self-citationPresynaptic Receptors Modulating Transmitter Release: Physiological and Pharmacological Aspects
Raiteri, M., Marchi, M., Maura, G., Bonanno, G., Pittaluga, A., Paudice, P., Gemignani, A., Pende, M., & Drago, C. (1992) · Pharmacochemistry library · doi:10.1016/b978-0-444-88931-7.50011-6 · Cited by 2
Self-citationNabatame, H., Sasa, M., Takaori, S., et al. (1988) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.46.387 · Cited by 2
AF102B: Preclinical Experience
Iga, Y., Ogane, N., Saito, Y., et al. (1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6738-1_39 · Cited by 2
Regulation of Dopamine Release by Muscarinic Receptors
Raiteri, M., Marchi, M., Pittaluga, A., et al. (1988) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-10047-7_25 · Cited by 1
Self-citationNeuropsychiatric Symptoms Related to Cholinergic Deficits in Parkinson’s Disease
Perez‐Lloret, S., Peralta, M. C., & Barrantes, F. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53126-7_27 · Cited by 1
“function partly as inhibitory autoreceptors on cholinergic terminals [23].”
BackgroundPresynaptic Cholinergic Mechanisms in Human Cerebral Cortex of Adult and Aged Patients
Marchi, M., Besana, E., Codignola, A., et al. (1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6738-1_11 · Cited by 1
Self-citationMuscarinic Receptors: Molecular Biology and Neuropsychopharmacology
Richelson, E. (1992) · Advances in behavioral biology · doi:10.1007/978-1-4615-3432-7_1 · Cited by 1
Subtypes of muscarinic receptors in cultured explants of the hippocampus of the rat
Waser, P. G. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90082-7 · Cited by 1
Rimvall, K., Keller, F., & Waser, P. G. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90647-x · Cited by 1
Dawson, R. M. (1989) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(89)90036-3 · Cited by 1
Iino, T., Katsura, M., & KURIYAMA, K. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90123-m · Cited by 1
Lin, C. J., & Cheng, J. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90504-5 · Cited by 1
Nabatame, H., Sasa, M., Takaori, S., et al. (1988) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)43292-7 · Cited by 1
Cholinergic Mechanisms in Schizophrenia
Raedler, T. J., & Freedman, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_2 · Cited by 1
PRADODECARVALHO, L. (1989) · Neurochemistry International · doi:10.1016/0197-0186(89)90070-3
Metadata
- Authors
- Raiteri, M., Leardi, R., & Marchi, M.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1984-01
- Volume
- 228
- Issue
- 1
- Pages
- 209-214
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1927364971
- Cited by
- 314
- References
- 0
- Citations by year
- 2025: 3 · 2024: 2 · 2022: 1 · 2021: 2 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 4 · 2013: 4 · 2012: 4
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- presynaptic muscarinic receptors, muscarinic autoreceptors, neurotransmitter release, acetylcholine release, dopamine release, striatum, hippocampus, cerebral cortex, oxotremorine, carbachol, pirenzepine, atropine, antimuscarinic agents, receptor heterogeneity
- MeSH terms
- Acetylcholine, Animals, Brain, Cerebral Cortex, Corpus Striatum, Dopamine, Hippocampus, Male, Parasympatholytics, Parasympathomimetics, Rats, Inbred Strains, Receptors, Muscarinic, Synaptosomes, Time Factors, Neurotransmitter Agents, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review